Company news
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) news
Recursion Pharmaceuticals, Inc. news releases on 6ix. Latest, Mar 18, 2022: Recursion Announces Enrollment of First Patient in Phase 2 Trial for the Treatment…
Press releases — page 3
Recursion Announces Enrollment of First Patient in Phase 2 Trial for the Treatment of Cerebral Cavernous Malformation
March 17, 2022
Recursion Provides Updated Guidance on Clinical Trial Starts
March 2, 2022
Recursion Announces Transformational Collaboration with Roche and Genentech in Neuroscience and Oncology, Advancing Novel Medicines to Patients Using Machine Learning and High Content Screening Methods at Scale to Map Complex Biology
December 6, 2021
Recursion and Bayer Expand Fibrosis Collaboration to Include Inferential Search Capabilities
December 5, 2021
Recursion Enhances its Leadership Team and Deepens Focus on Neuroscience with Three Senior Appointments
November 29, 2021
Recursion Provides Business Updates and Reports Third Quarter 2021 Financials
November 9, 2021
Recursion is Granted FDA Fast Track Designation for REC-2282 for the Potential Treatment of NF2-Mutated Meningiomas
October 6, 2021
Recursion is Granted Orphan Drug Designation for REC-4881 for the Potential Treatment of Familial Adenomatous Polyposis
September 28, 2021
Recursion Reports Second Quarter 2021 Financials and Provides Business Updates
August 12, 2021
Recursion Announces Therapeutics Advisory Board, Chaired by Joseph Miletich, MD, PhD
July 12, 2021
Recursion Opens Child Care Center to Support Employees
July 11, 2021
Recursion Signs Lease With Vestar for an Additional 100,000 sf of Space at the Gateway in Downtown Salt Lake City
June 30, 2021
Recursion Announces Multi-Year Collaboration with Mila for Tech-Enabled Drug Discovery
June 22, 2021
Recursion Announces its First Major Multidisciplinary Expansion, in Toronto, to Further Tech-Enabled Drug Discovery
June 14, 2021
Recursion Announces First Internally-Developed NCE Advanced to IND-Enabling Studies to Potentially Treat Clostridium difficile Colitis
May 24, 2021
Recursion Reports First Quarter 2021 Financials and Provides Business Updates
May 11, 2021
Recursion Pharmaceuticals Announces Closing of Initial Public Offering
April 20, 2021
Recursion Pharmaceuticals Announces Pricing of Initial Public Offering
April 15, 2021